Clostridium (Clostridioides) difficile ribotype 027 (RT027) was detected in Germany for the first time in 2007 during an outbreak in the region of Trier, Rhineland-Palatinate and is today the most prevalent ribotype (RT) in Europe. We aimed to determine the changes in RT distribution and corresponding antimicrobial resistance in clinical C. difficile isolates between two time points (2007 and 2017) in one tertiary care hospital in Germany. C. difficile isolates recovered in 2007 and in 2017 (80 isolates per year, respectively) from patients at a Tertiary Care University Hospital in North-Rhine Westphalia were analyzed. Isolates were characterized by ribotyping and susceptibility testing using gradient tests (metronidazole, vancomycin) and t...
Clostridium difficile infection (CDI) has been primarily treated with metronidazole or vancomycin. H...
Clostridium difficile infection (CDI) has been primarily treated with metronidazole or vancomycin. H...
AbstractClostridium difficile infection remains a major healthcare burden. Until the recent introduc...
We characterized 670 Clostridium diffi cile isolates collected from patients in 84 hospitals in Ger...
Clostridium difficile infection remains a major healthcare burden. Until the recent introduction of ...
Clostridium difficile infection remains a major healthcare burden. Until the recent introduction of ...
We characterized 670 Clostridium difficile isolates collected from patients in 84 hospitals in Germa...
The aims of this study were to investigate any change in PCR ribotypes and to determine the antimicr...
International audienceThe prevalence of Clostridioides difficile PCR-ribotype (RT) 018 is low in Eur...
Aim: To obtain standardized epidemiological data for Clostridium difficile infection (CDI) in Slovak...
We determined the PCR ribotypes and antimicrobial susceptibility patterns of 508 toxigenic Clostridi...
Outbreaks of Clostridium difficile infections (CDI) with increased severity, high relapse rate and s...
Abstract 23 We determined the PCR ribotypes and antimicrobial susceptibility patterns of 508 24 toxi...
Clostridioides difficile is a Gram positive spore-forming rod and mainly responsible for nosocomial ...
From January 2008 to April 2009, 72 cases of severe Clostridium difficile infection were reported fr...
Clostridium difficile infection (CDI) has been primarily treated with metronidazole or vancomycin. H...
Clostridium difficile infection (CDI) has been primarily treated with metronidazole or vancomycin. H...
AbstractClostridium difficile infection remains a major healthcare burden. Until the recent introduc...
We characterized 670 Clostridium diffi cile isolates collected from patients in 84 hospitals in Ger...
Clostridium difficile infection remains a major healthcare burden. Until the recent introduction of ...
Clostridium difficile infection remains a major healthcare burden. Until the recent introduction of ...
We characterized 670 Clostridium difficile isolates collected from patients in 84 hospitals in Germa...
The aims of this study were to investigate any change in PCR ribotypes and to determine the antimicr...
International audienceThe prevalence of Clostridioides difficile PCR-ribotype (RT) 018 is low in Eur...
Aim: To obtain standardized epidemiological data for Clostridium difficile infection (CDI) in Slovak...
We determined the PCR ribotypes and antimicrobial susceptibility patterns of 508 toxigenic Clostridi...
Outbreaks of Clostridium difficile infections (CDI) with increased severity, high relapse rate and s...
Abstract 23 We determined the PCR ribotypes and antimicrobial susceptibility patterns of 508 24 toxi...
Clostridioides difficile is a Gram positive spore-forming rod and mainly responsible for nosocomial ...
From January 2008 to April 2009, 72 cases of severe Clostridium difficile infection were reported fr...
Clostridium difficile infection (CDI) has been primarily treated with metronidazole or vancomycin. H...
Clostridium difficile infection (CDI) has been primarily treated with metronidazole or vancomycin. H...
AbstractClostridium difficile infection remains a major healthcare burden. Until the recent introduc...